Company / Operating Income per Share
REGENXBIO Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.25
FY2025
5-year range
-$6.19 / -$3.25
FY2021-FY2025
Trend
+38.6%
vs FY2024
Sector context
#143 of 201
Health Care
What the data says
At $-3.25, REGENXBIO Inc.'s operating income per share ranks #143 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-6.19 in FY2023 to $2.82 in FY2018.
Based on SEC 10-K filings.
-3.25 in FY2025.
Improved from $-6.19 to $-3.25 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 71% of 201This company -$3.25 Sector average -$3.23
▼
In line with sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 38.6% year-over-year.
- Ranks #143 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2018.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.25 | +38.6% |
| FY2024 | -$5.30 | +14.4% |
| FY2023 | -$6.19 | -0.9% |
| FY2022 | -$6.14 | -54.4% |
| FY2021 | -$3.98 | -266.9% |
| FY2020 | $2.38 | +213.4% |
| FY2019 | -$2.10 | -174.6% |
| FY2018 | $2.82 | +198.2% |
| FY2017 | -$2.87 | -1948.2% |
| FY2016 | -$0.14 | +92.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026